Freshpet Rallies into Earnings as Shorts Hold Firm at 17%
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Freshpet reported Q3 results on November 4 with the stock up 8% on the week, yet short sellers remain dug in at levels that keep the fundamental debate firmly unresolved.
The clearest tension in the data is between price action and positioning. The stock closed at $69.60, up 15% over the past month, yet short interest has moved in the same direction. Shorts now account for nearly 17% of the free float, up roughly 9% over the past month, with 8.27 million shares sold short. That is a material and growing short book building into, and apparently not shaken by, a strong earnings-week rally. The borrow market itself is relaxed: the cost to borrow has drifted lower to 0.39%, and availability is running at around 235% of short interest, meaning there is roughly 2.3 times as much stock available to borrow as is currently being borrowed. The lending pool is not tight, and short sellers face no mechanical pressure to cover. Options traders, meanwhile, have shifted more bullish than usual. The put/call ratio has dropped to 0.57, sitting below its 20-day average of 0.63 and near the lower end of its 52-week range of 0.47 to 1.55. That divergence, options leaning bullish while shorts rebuild, is the defining tension on this ticker right now.
The Street is broadly constructive but trimming expectations. JP Morgan maintained its Overweight rating last week while nudging its target down from $78 to $76. TD Cowen and Wells Fargo both cut targets in October, to $80 and $77 respectively, while keeping positive ratings. The mean price target across the analyst panel is $83.19, implying roughly 20% upside from the current price. Morgan Stanley is the notable outlier, having downgraded to Equal-Weight in August after the last earnings report. Needham started coverage in October with a Hold. The valuation picture reflects the stock's re-rating: the price-to-earnings multiple has expanded about 4 points over the past month to 36.5x, and price-to-book has climbed nearly 0.3 points to 2.76x. The EPS surprise factor score ranks in the 93rd percentile, showing consistent beat history. Forward earnings momentum is weaker though, with the 12-month forward EPS growth score at just the 7th percentile, a flag the bears are leaning on.
The bull and bear cases are well-defined. Bulls point to refrigerated pet food still accounting for less than 3% of total dog food volume, leaving a long runway for category growth, plus execution on distribution at Costco, Walmart, and Tractor Supply, and a manufacturing cost trajectory pointing toward gross margins approaching 49% and adj. EBITDA margins near 20% in 2027. Bears focus on slowing household penetration gains, competitive pressure from Blue Buffalo and Kirkland on pricing, and the risk that input and logistics costs prevent the company from clearing the margin bar the market is pricing in. The Q3 print on November 4, which produced a 3% single-day gain, appears to have cleared a floor rather than resolved the debate. The last major report, in August, delivered a 7% single-day move and a 16% five-day gain, but was followed by the Morgan Stanley downgrade.
On the ownership side, the institutional base is stable. BlackRock holds around 12% of shares, with Wasatch Advisors, Capital Research, and two Vanguard vehicles each near 6%. Wellington Management added nearly 300,000 shares in its most recent filing. AllianceBernstein built its position by over 500,000 shares in the period to August. No 13D activist holders are on the register. The insider picture is less clear as a signal: net insider activity over the past 90 days shows roughly 215,000 shares sold net, with the CEO's late-August transactions executed under a pre-arranged 10b5-1 plan, making them a compensation mechanism rather than a conviction trade. A director made a small open-market purchase of 1,000 shares in September at $64.92, notable mainly because discretionary buying at this level is rare in the recent record.
Wikipedia attention for Freshpet is running above its own 90-day average, with a retail attention z-score of 1.2 as of mid-October. No alt-data datasets have been measured as leading indicators of the company's reported financials, so this reading is colour rather than signal.
The next earnings event is not until February 12. What to watch between now and then is whether short sellers use the post-earnings rally to add further to a position already at 17% of float, or whether the combination of improving margin rhetoric and bullish options positioning starts to erode that short book as Q4 data emerges.
Stocks in this article
See the live data behind this article on ORTEX.
Open FRPT on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 20:04
- Data as of
- 4 Nov 2026, 20:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.